Gene · 57167
Papers3,058
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,058
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cytoplasmic SALL4-A isoform expression as a diagnostic marker of less aggressive tumor behavior in gastric cancer. | World J Surg Oncol | 2025 | 39905414 | PubTator, text mining | PubMed |
SALL4 as a Useful Marker for the Distinction of Various Gestational Trophoblastic Disease Subtypes: Choriocarcinoma From Other Trophoblastic Lesions and Early Complete Hydatidiform Mole From Partial Mole and NonMolar Villi. | Am J Surg Pathol | 2025 | 39876093 | PubTator, text mining | PubMed |
| Activation of the 26S Proteasome to Reduce Proteotoxic Stress and Improve the Efficacy of PROTACs. | ACS Pharmacol Transl Sci | 2025 | 39816802 | PubTator, text mining | PubMed |
| Gastric Adenocarcinoma with Enteroblastic Differentiation. | Pathobiology | 2025 | 39773736 | PubTator, text mining | PubMed |
| Complex immunohistochemical and molecular study on 5 cases of ovarian juvenile granulosa cell tumors reveals a consistent alteration in the PI3K/AKT/mTOR signaling pathway. | Diagn Pathol | 2025 | 39773640 | PubTator, text mining | PubMed |
| Paratesticular/inguinal SMARCB1/INI1 deficient carcinomas with yolk sac tumour-like differentiation are aggressive somatic malignancies. | Histopathology | 2025 | 39762201 | PubTator, text mining | PubMed |
| Nucleosome fibre topology guides transcription factor binding to enhancers. | Nature | 2025 | 39695228 | PubTator, text mining | PubMed |
Concurrent Pit-1 and SALL4 staining in primitive component of pituitary blastoma: A case report with clinicopathologic features including Cushing syndrome presentation, germline DICER1 mutation, and significant therapeutic response to chemoradiation. | J Neuropathol Exp Neurol | 2025 | 39656999 | PubTator, text mining | PubMed |
| Comprehensive RNA Sequencing Analysis Identifies Network Hub Genes and Biomarkers Differentiating Desmoid-type Fibromatosis From Reactive Fibrosis. | Lab Invest | 2025 | 39617099 | PubTator, text mining | PubMed |
| A Unique Case of Bilateral Testicular Tumours: Nonseminomatous Germ Cell Tumour and Contralateral Spermatocytic Tumour 27 Years Apart. | Urol Int | 2025 | 39571541 | PubTator, text mining | PubMed |
| Conserved helical motifs in the IKZF1 disordered region mediate NuRD interaction and transcriptional repression. | Blood | 2025 | 39437550 | PubTator, text mining | PubMed |
| Urothelial Carcinoma with Trophoblastic Differentiation-A Report with Review. | Int J Surg Pathol | 2025 | 39161232 | PubTator, text mining | PubMed |
| Clinicopathological and molecular features of genome-stable colorectal cancers. | Histol Histopathol | 2025 | 38993017 | PubTator, text mining | PubMed |
| Gastric adenocarcinoma with enteroblastic differentiation in a 67-year-old man in Korea: a case report. | Ewha Med J | 2024 | 40703682 | PubTator, text mining | PubMed |
| Gastric Cancer Showing Rapid Recurrence and Progression: A Case of Gastric Adenocarcinoma With Enteroblastic Differentiation. | Korean J Helicobacter Up Gastrointest Res | 2024 | 40503278 | PubTator, text mining | PubMed |
| [A Case of Esophagogastric Junction Tumor Diagnosed as an Adenocarcinoma with Enteroblastic Differentiation]. | Gan To Kagaku Ryoho | 2024 | 39948853 | PubTator, text mining | PubMed |
| Novel Syndrome With Congenital Thumb Aplasia, Epilepsy, Cognitive Impairment, and Myopathy: A Case Report. | Cureus | 2024 | 39850168 | PubTator, text mining | PubMed |
| Corrigendum: The impact of non-coding RNAs in the epithelial to mesenchymal transition. | Front Mol Biosci | 2024 | 39722893 | PubTator, text mining | PubMed |
| [Primary uterine hepatoid adenocarcinoma: Clinicopathological analysis of 2 cases and literature review]. | Beijing Da Xue Xue Bao Yi Xue Ban | 2024 | 39690782 | PubTator, text mining | PubMed |
| [Primary intracranial DICER1-mutant sarcoma: a clinicopathological analysis of seven cases]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 39648006 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57167/papers?page=10